|Zuclopenthixol (as hydrochloride)
|Zuclopenthixol (as acetate)
|Zuclopenthixol (as decanoate)
|Flupentixol (as dihydrochloride)
|Flupentixol (as decanoate)
Federal regulations limit the scope of information that pharmaceutical companies are authorized to give on prescription drugs via the internet or other means. To obtain more detailed information on the properties or appropriate use of any prescription drug, please consult a qualified health care professional. The products discussed herein may have different product labeling in different countries. The product information on this site is intended only for residents of Canada.
Ebixa® is a registered trademark of Merz Pharma GmbH, used under license by Lundbeck Canada Inc.
Abilify Maintena® and Rexulti® are registered trademarks of Otsuka Pharmaceutical Co., Ltd, marketed by Otsuka Canada Pharmaceutical Inc., and Lundbeck Canada Inc.
Sabril® is a Lundbeck LLC product, used under license by Lundbeck Canada Inc.. For medical information regarding this product, please visit the Lundbeck US Product site.
Vyepti® is a registered trademark of H. Lundbeck A/S, used under license by Lundbeck Canada Inc.
As part of our commitment to ensuring the safe and effective collection and disposal of expired and/or unused health products, Lundbeck Canada is a member of the Health Products Stewardship Association. Their programs provide a safe and convenient way for consumers to dispose of unused or expired household medications (medical sharps) in an environmentally responsible manner.
To learn more about properly storing and handling pharmaceuticals and medical sharps or finding a collection location near you, we encourage you to visit the HPSA website.
R&D of new and improved treatments is at the core of what we do.
We are singularly focused on advancing therapies for brain diseases.
Discover our projects and compounds in development.